IBDEI2XH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46728,1,3,0)
 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
 ;;^UTILITY(U,$J,358.3,46728,1,4,0)
 ;;=4^N13.1
 ;;^UTILITY(U,$J,358.3,46728,2)
 ;;=^5015576
 ;;^UTILITY(U,$J,358.3,46729,0)
 ;;=N13.2^^179^2329^7
 ;;^UTILITY(U,$J,358.3,46729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46729,1,3,0)
 ;;=3^Hydronephrosis w/ Renal & Ureteral Calculous Obstruction
 ;;^UTILITY(U,$J,358.3,46729,1,4,0)
 ;;=4^N13.2
 ;;^UTILITY(U,$J,358.3,46729,2)
 ;;=^5015577
 ;;^UTILITY(U,$J,358.3,46730,0)
 ;;=N13.30^^179^2329^11
 ;;^UTILITY(U,$J,358.3,46730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46730,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,46730,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,46730,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,46731,0)
 ;;=N13.39^^179^2329^10
 ;;^UTILITY(U,$J,358.3,46731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46731,1,3,0)
 ;;=3^Hydronephrosis,Other
 ;;^UTILITY(U,$J,358.3,46731,1,4,0)
 ;;=4^N13.39
 ;;^UTILITY(U,$J,358.3,46731,2)
 ;;=^5015579
 ;;^UTILITY(U,$J,358.3,46732,0)
 ;;=N13.4^^179^2329^12
 ;;^UTILITY(U,$J,358.3,46732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46732,1,3,0)
 ;;=3^Hydroureter
 ;;^UTILITY(U,$J,358.3,46732,1,4,0)
 ;;=4^N13.4
 ;;^UTILITY(U,$J,358.3,46732,2)
 ;;=^186913
 ;;^UTILITY(U,$J,358.3,46733,0)
 ;;=N13.5^^179^2329^6
 ;;^UTILITY(U,$J,358.3,46733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46733,1,3,0)
 ;;=3^Crossing Vessel & Stricture of Ureter w/o Hydronephrosis
 ;;^UTILITY(U,$J,358.3,46733,1,4,0)
 ;;=4^N13.5
 ;;^UTILITY(U,$J,358.3,46733,2)
 ;;=^5015580
 ;;^UTILITY(U,$J,358.3,46734,0)
 ;;=N13.6^^179^2329^29
 ;;^UTILITY(U,$J,358.3,46734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46734,1,3,0)
 ;;=3^Pyonephrosis
 ;;^UTILITY(U,$J,358.3,46734,1,4,0)
 ;;=4^N13.6
 ;;^UTILITY(U,$J,358.3,46734,2)
 ;;=^101552
 ;;^UTILITY(U,$J,358.3,46735,0)
 ;;=N16.^^179^2329^31
 ;;^UTILITY(U,$J,358.3,46735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46735,1,3,0)
 ;;=3^Renal Tubulo-Interstitial D/O in Diseases Classd Elswhr
 ;;^UTILITY(U,$J,358.3,46735,1,4,0)
 ;;=4^N16.
 ;;^UTILITY(U,$J,358.3,46735,2)
 ;;=^5015597
 ;;^UTILITY(U,$J,358.3,46736,0)
 ;;=N17.0^^179^2329^19
 ;;^UTILITY(U,$J,358.3,46736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46736,1,3,0)
 ;;=3^Kidney Failure,Acute w/ Tubular Necrosis
 ;;^UTILITY(U,$J,358.3,46736,1,4,0)
 ;;=4^N17.0
 ;;^UTILITY(U,$J,358.3,46736,2)
 ;;=^5015598
 ;;^UTILITY(U,$J,358.3,46737,0)
 ;;=N17.1^^179^2329^17
 ;;^UTILITY(U,$J,358.3,46737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46737,1,3,0)
 ;;=3^Kidney Failure,Acute w/ Acute Cortical Necrosis
 ;;^UTILITY(U,$J,358.3,46737,1,4,0)
 ;;=4^N17.1
 ;;^UTILITY(U,$J,358.3,46737,2)
 ;;=^5015599
 ;;^UTILITY(U,$J,358.3,46738,0)
 ;;=N17.2^^179^2329^18
 ;;^UTILITY(U,$J,358.3,46738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46738,1,3,0)
 ;;=3^Kidney Failure,Acute w/ Medullary Necrosis
 ;;^UTILITY(U,$J,358.3,46738,1,4,0)
 ;;=4^N17.2
 ;;^UTILITY(U,$J,358.3,46738,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,46739,0)
 ;;=N17.8^^179^2329^21
 ;;^UTILITY(U,$J,358.3,46739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46739,1,3,0)
 ;;=3^Kidney Failure,Other Acute
 ;;^UTILITY(U,$J,358.3,46739,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,46739,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,46740,0)
 ;;=N17.9^^179^2329^20
 ;;^UTILITY(U,$J,358.3,46740,1,0)
 ;;=^358.31IA^4^2
